Deakin University
Browse
ip-costeffevtivenessof-2020.pdf (1.59 MB)

The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era

Download (1.59 MB)
journal contribution
posted on 2020-03-01, 00:00 authored by A Vasudevan, Francis IpFrancis Ip, D Liew, D R Van Langenberg
The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era

History

Journal

Inflammatory Bowel Diseases

Volume

26

Issue

3

Pagination

369 - 379

Publisher

Oxford University Press

Location

Oxford, Eng.

Publisher DOI

Link to full text

ISSN

1078-0998

eISSN

1536-4844

Language

eng

Author URL

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    ADALIMUMABazathioprinebiologicsCOMBINATION THERAPYDOSE INTENSIFICATIONeconomicGastroenterology & HepatologyINFLAMMATORY-BOWEL-DISEASEINFUSION THERAPYLife Sciences & BiomedicineLONG-TERMMAINTENANCE TREATMENTMarkovMARKOV MODELREMISSIONScience & Technologytumor necrosis factor

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC